New HORIBA Medical Corporate Clip 2019
The HORIBA Medical Segment designs, develops and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories. These automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics and university hospitals. HORIBA expertise in in vitro diagnostics is one of the most respected in hematology worldwide and contribute today to the health of tomorrow.
Results, the only thing that matters.
The new generation of HORIBA Medical automated hematology analyzer answers customer's expectations of solid and reliable diagnostic technology as well as rapid and consistent results.
Picture not contractually binding
"My Companions for Hemostasis Diagnostics"
As announced during EuroMedLab 2017, we are expanding our commercial offer with new comprehensive range of instruments and reagents in the hemostasis field:
Yumizen G100 - Yumizen G200 - Yumizen G400 - Yumizen G800 - Yumizen G1550
We now would like to move forward with you for an efficient roll-up of the Yumizen Hemostasis Range worldwide.
|
|
|
|
|
|---|
01.08.2020 - QSP 2.0: An Affordable Digital tool for “Skills Evaluation & Training” in blood morphology
21.07.2020 - Montpellier and Grenoble, France, July 21, 2020 HORIBA Medical, a subsidiary of Japan-based HORIBA...
15.07.2020 - HORIBA Medical has established a partnership with BioMedica Diagnostics Inc. (BMD)